April 2016 – Tests for suspected lung cancer reveal cysts on the pancreas. This was never disclosed to Pat, no follow up was recommended and it was considered insignificant. The first we knew of it was after the Pancreatic cancer diagnosis in May 2017.
5 May 2017 – Admitted to ICU with Pulmonary Embolism from DVT. Mass on pancreas detected on CT. Bloodwork completed showed elevated CA19-9 at around 8000.
20 May 2017 – Returned to Australia to begin investigation and treatment of cancer
22 May 2017 – GP for referral. GP believed there’s no cancer – highly critical of Thai doctors and diagnosis. Suggests there’s nothing to worry about. Haemotologist in the afternoon – he was more concerned
26 May 2017 – first appointment with oncologist. Our worst fears were confirmed. He believes it is undoubtedly pancreatic cancer. Recommendation of immediate referral to the public health system for treatment.
31 May 2017 – First appointment with public health oncologist. Recommendation for a biopsy and PET scan. There’s a possibility it’s not a carcinoma but a lymphoma, this is a good thing.
1 June 2017 – PET Scan
5 June – PET scan results. Cancer has been detected in pancreas, spleen, liver, kidneys and lymph nodes. Decision to biopsy the groin has been made as a general anesthetic isn’t considered safe with a pulmonary embolism.
9 June – Biopsy of metastasised tumor in groin
19 June – Appointment to discuss results of groin biopsy. No cells were detected in the biopsy. A new biopsy is required.
21 June – After a 5 hour wait (and overnight fasting) the biopsy is rescheduled for the next day
22 June – a successful endoscopic biopsy of the mass in the pancreas.
26 June – 51 days after the diagnosis in Bangkok, the doctors in Australia confirm the diagnosis of pancreatic cancer. Due to the widespread nature it’s consider metastatic and stage 4. Chemo regime of Abraxane & Gemcitabine and is recommended to slow the growth and will begin within days
29 June – Chemo round 1, day 1. No side effects. Supported with steriods for symptom management.